Search Within

Stuart Lichtman

  1. "2005"
Formats
  1. Journal Article (17)
Groups
  1. Department of Medicine (17)
  2. Gynecologic Medicine Service (17)
  3. Solid Tumor Oncology Division (17)
Years
  1. 2005 (17)
Publications
  1. The Oncology Report (12)
  2. Cancer Investigation (1)
  3. Community Oncology (1)
  4. Critical Reviews in Oncology/Hematology (1)
  5. Oncology (Norwalk) (1)
  6. The Oncologist (1)
Publishers
  1. International Medical News Group LLC (12)
  2. C M P Medica LLC * The Oncology Group (1)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)
  5. Informa Healthcare (1)
  6. Oxford University Press (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly
    Journal Article

    Wasil, T.; Lichtman, S. M.
    The Oncologist (2005)

    Fulltext@MSK | Save
  • Treatment of elderly cancer patients with chemotherapy
    Journal Article

    Wasil, T.; Lichtman, S. M.
    Cancer Investigation (2005)

    Fulltext@MSK | Save
  • Capecitabine better than bolus 5-FLU/leucovorin as adjuvant therapy for Dukes' C cancer
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Bevacizumab can be safely combined with FOLFOX or XELOX
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Front-line XELOXA regimen delays progression of metastatic colorectal cancer
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Microsatellite instability status may aid in treatment decisions for colorectal cancer
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Some colorectal cancer patients who have exhausted other options respond to cetuximab
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Studies show improved survival with bevacizumab/FOLFOX4 for colorectal cancer
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Adjuvant capecitabine at least equivalent to 5-FU/LV in colon cancer
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save
  • Trial favors FLOX over 5-FU/LV for stage II, III colon cancer - Comment
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2005)

    Fulltext@MSK | Save